SCHEMBL31426

SCHEMBL31426

CCNS(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2748684 0.97
SCHEMBL11513414 0.97
Diethylamine SCHEMBL20946172 0.91 TP53 (0.47)
Formic Acid SCHEMBL17362051 0.86 CA2 (0.36)
SCHEMBL242031 0.77
SCHEMBL15673083 0.76 CA1 (0.36)
SCHEMBL7163145 0.76
SCHEMBL3871336 0.74
SCHEMBL27252944 0.74 CA2 (0.41)
SCHEMBL3043384 0.74 POLB (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1832 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4182322-B1 PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS CHIESI FARM SPA (IT) 2024-04-24 EP claimed
US-20240116947-A1 PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-04-11 US claimed
EP-4182322-A1 PYRIDO OXAZINE DERIVATIVES AS ALK5 INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2023-05-24 EP claimed
EP-2694505-B1 HSP90 INHIBITORS SLOAN KETTERING INST CANCER RES (US) 2022-04-27 EP claimed
US-10201623-B2 HSP90-targeted cardiac imaging and therapy MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2019-02-12 US claimed
US-9745305-B2 Modulators of methyl modifying enzymes, compositions and uses thereof CONSTELLATION PHARMACEUTICALS, INC. (US) 2017-08-29 US claimed
EP-2970305-B1 MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF CONSTELLATION PHARMACEUTICALS INC (US) 2017-02-22 EP claimed
EP-3091984-A1 SUBSTITUTED BENZOXAZINE AND RELATED COMPOUNDS The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone (US) 2016-11-16 EP claimed
US-20160264577-A1 HSP90 INHIBITORS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 2016-09-15 US claimed
EP-2970305-A1 MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF Constellation Pharmaceuticals, Inc. (US) 2016-01-20 EP claimed
EP-0495594-B1 Sulphonamide derivatives ZENECA LTD (GB) 1996-03-20 EP claimed
US-5414084-A Reaction 2-aminopyrimidine or amino-1,3,5-triazine derivative; purity; by-product inhibition HOECHST AKTIENGESELLSCHAFT (DE) 1995-05-09 US claimed
EP-0589018-A1 AMINES AS INHIBITORS OF SQUALENE SYNTHASE ZENECA LIMITED (GB) 1994-03-30 EP claimed
WO-1993020807-A1 AMINES AS INHIBITORS OF SQUALENE SYNTHASE ZENECA LIMITED (GB) 1993-10-28 WO claimed
US-5180826-A Multistage reaction of chlorosulfonylisocyanate and methane sulfonylethylamine and reacting with aminopyrimidine LONZA LTD. (CH) 1993-01-19 US claimed
EP-0495594-A1 Sulphonamide derivatives ZENECA LIMITED (GB) 1992-07-22 EP claimed
US-5011928-A Analgesic and antiinflammatory derivatives of 1-acyl-4-arylalkylpiperazines FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMECEUTI COS S.A. (FAES) (ES) 1991-04-30 US claimed
EP-0385044-A1 New piperidine derivatives as antihistaminics FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A. (FAES) (ES) 1990-09-05 EP claimed
EP-0074894-B1 PROCESS FOR THE PURIFICATION OF A GASEOUS MIXTURE CONTAINING UNDESIRABLE GASEOUS COMPOUNDS COMPAGNIE FRANCAISE DE RAFFINAGE Société anonyme dite: (FR) 1985-01-02 EP claimed
US-4170547-A SOLVENT EXTRACTION COMPAGNIE FRANCAISE DE RAFFINAGE (FR) 1979-10-09 US claimed